The growth of human breast cancer cells is inhibited by overexpression of PPAR in human breast cancer cell lines, triggering serious lipid cumulation and promoting cell phenotype changes, and leading to the increase of cell differentiation and the decrease of malignant degree (Román et al., 1007). Here, PPARA is linked to breast carcinoma.